DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 08/03/2023 declared a dividend of $0.7500 per share

Gilead Sciences Inc (NASDAQ:GILD) on 08/03/2023 declared a dividend of $ 0.7500 per share payable on September 28, 2023 to shareholders of record as of September 15, 2023.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 3.9640591145% and has increased its dividends for 7 successive years.

Gilead Sciences Inc's market cap is $ 94,399,675,040 and has a PE ratio of 17.08. The stock price closed yesterday at $ 75.68 and has a 52 week low/high of $ 60.62 and $ 89.74.

Gilead Sciences is a biopharmaceutical company, focusing on medicines to prevent and treat diseases, including HIV, viral hepatitis and cancer. Co.'s products include: Biktarvy®, which is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), an injection for intravenous use, which is a nucleotide analog RNA polymerase inhibitor indicated for certain patients for the treatment of COVID-19 requiring hospitalization; and Epclusa®, which is an oral formulation of a once-daily single tablet regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients.

For more information on Gilead Sciences Inc click here.